Randomized Trial of Alternative Quadrivalent Human Papilloma Virus (HPV) Vaccination Schedules in a University Setting
Completed
This is a randomized, open label trial of HPV (human papilloma virus) vaccine, comparing an on-time administration of the third dose with delayed administration of the third dose. All participants would receive the first and second doses according to schedule. They would be randomized to either vaccine at 6 months or vaccine at 12 months. Blood will be drawn for titers twice from all participants: pre-dose 1 and one month post third dose. We hypothesize that the GMTs in the test group (T) are n... Read More
Gender:
FEMALE
Ages:
Between 18 years and 23 years
Trial Updated:
08/11/2010
Locations: University of Pittsburgh, Pittsburgh, Pennsylvania
Conditions: Human Papillomavirus Infection